What Happened?
Los Angeles, CA-based Appia-Bio Appointed JeenJoo Kang as Chief Executive Officer
About the Company
Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
About the Person
JeenJoo Kang is Chief Executive Officer at Appia Bio. Previously, JeenJoo held various senior HR leadership roles in the industry.
Info Source
News
Short Profile